Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II

See also
Status	Clinical Trial	Phase
Completed	`NCT01627808` - Fluid Optimization in Liver Surgery	N/A
Withdrawn	`NCT05109052` - Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma	Phase 1/Phase 2
Recruiting	`NCT05179824` - Tempus Priority Study: A Pan-tumor Observational Study
Recruiting	`NCT03896958` - The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Completed	`NCT05030090` - Integrative Nutrition Care Plan for the Patient With Liver and Colorectal Cancer	N/A
Terminated	`NCT00669136` - Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma	Phase 1
Recruiting	`NCT04258813` - Onco-primary Care Networking to Support TEAM-based Care	N/A
Completed	`NCT03299036` - Drug-loadable（T-ACE Beads）for Hepatoma Embolization Therapy	N/A
Recruiting	`NCT03323996` - Impact of a Training in Therapeutic Education on the Relation Between Care Givers and Their Patients	N/A
Completed	`NCT02044224` - Effects of Dexmedetomidine During IRE Procedures for Solid Tumours	Phase 4
Not yet recruiting	`NCT03607643` - A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies	Phase 1/Phase 2
Completed	`NCT05643833` - Impact of Gender on the Outcome of Liver Transplantation for Hepatocellular Carcinoma
Recruiting	`NCT03452774` - SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Not yet recruiting	`NCT03766776` - Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC)	N/A
Completed	`NCT02016391` - Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours	Phase 4
Recruiting	`NCT00730860` - Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE	N/A
Terminated	`NCT00216437` - Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma	Phase 1
Completed	`NCT04172714` - Low-dose Y90 Treatment Planning for HCC	N/A
Active, not recruiting	`NCT03347162` - Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer
Recruiting	`NCT04348838` - Prospective Cohort of Patients With Hepatocellular Carcinoma in France

NCT number	NCT05907772
Study type	Observational
Source	Zhejiang University
Contact
Status	Completed
Phase
Start date	August 27, 2022
Completion date	November 10, 2022

Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular Carcinoma

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms